HCTI
Healthcare Triangle, Inc.
There isn't enough reported data to score HCTI yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
HCTI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Unavailable | |
| Unavailable |
HCTI's revenue is currently strong, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
HCTI PE Valuation
HCTI has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
HCTI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect HCTI's losses to grow, with revenue growing.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
HCTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$262,944.00 | +$19,558.66 |
| Q4 2024 | -$337,644.00 | +$48,323.57 |
HCTI has the edge over HIMS in the latest year-over-year earnings comparison.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
HCTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $9.2M | +158% |
| Q1 2026 | $9.9M | +166% |
| Q4 2025 | $3.1M | +43% |
| Q3 2025 | $3.5M | +45% |
| Q2 2025 | $3.6M | +19% |
| Q1 2025 | $3.7M | -9.9% |
| Q4 2024 | $2.2M | -69% |
| Q3 2024 | $2.4M | -69% |
HCTI's revenue is recovering but still below its 2022 peak: $9M last quarter, up 158% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -44% | -6.1 points |
| Q1 2026 | -37% | +1 points |
| Q4 2025 | -142% | -119 points |
| Q3 2025 | -74% | -26 points |
| Q2 2025 | -38% | +8 points |
| Q1 2025 | -38% | +3.8 points |
| Q4 2024 | -23% | -3.4 points |
| Q3 2024 | -48% | -29 points |
HCTI's operating margin was −44% last quarter, down 6.1 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over HCTI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over HCTI on profitability, with a higher operating margin.
HCTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$6.9M | -$1.3M |
| Q4 2023 | $594K | +$2.8M |
| Q2 2023 | -$1.2M | -507% |
| Q1 2023 | -$1.6M | -631% |
| Q4 2022 | -$2.2M | +$1.2M |
HCTI has burned cash in most quarters: −$21M over the past year, against −$4M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over HCTI in the latest year-over-year cash flow comparison.
HCTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +201% | +93.7K shares |
| 1 year | +779217% | +140K shares |
HCTI has 140,277 diluted shares, up 779217% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | $51,000 |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over HCTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
HCTI Net Leverage
HCTI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
HCTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.8 | Neutral |
| Stochastic | 0.2 | Oversold |
HCTI's weekly RSI is 33 (neutral) and its Stochastic is 0 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
HCTI PE vs Healthcare Sector
HCTI has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
HCTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.37 | 55% below |
| 20 week MA | $18.1 | 79% below |
| 50 week MA | $269.1 | 99% below |
| 100 week MA | $34,100.7 | 100% below |
| 200 week MA | $360,400.1 | 100% below |
HCTI is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HCTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10,338,480.0 | $5,378,400.0 | -48% |
| 2022 | $5,378,400.0 | $624,492.0 | -88% |
| 2023 | $624,492.0 | $815,724.0 | +31% |
| 2024 | $815,724.0 | $237,130.7 | -71% |
| 2025 | $237,130.7 | $1,380.0 | -99% |
| 2026 YTD | $1,380.0 | $3.74 | -100% |
HCTI has finished lower in four of the last five years. It's down 100% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over HCTI on returns for 2026, with the stronger performance.